Market Cap (In USD)
3.13 Million
Revenue (In USD)
-
Net Income (In USD)
-19.93 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0075-0.008
- PE
- -
- EPS
- -
- Beta Value
- 0.247
- ISIN
- US68236V1127
- CUSIP
- -
- CIK
- 1690080
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mr. Lloyd Blair Jordan L.L.B., M.B.A.
- Employee Count
- -
- Website
- http://www.180lifesciences.com
- Ipo Date
- Details
- 180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
More Stocks
-
BITBiotron Limited
BIT
-
PRG
-
MEDICAPQMedi-Caps Limited
MEDICAPQ
-
9325PHYZ Holdings Inc.
9325
-
688786
-
301019
-
605339
-
TRS